Skip to content

CapEx at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
$347M+33.5%
Pfizer logo
PfizerPFE
$436M-22.7%
Johnson & Johnson logo
Johnson & JohnsonJNJ
$1.05B+31.9%
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
$230.6M+0.6%
Cytokinetics logo
CytokineticsCYTK
$5.93M+4.7%
Phibro Animal Health logo
Phibro Animal HealthPAHC
$15.32M+97.7%

Other financials

Income statement

See full
Revenue$16.3B+4.9%
Gross profit$12.1B-0.2%
Net income-$4.2B-183%
EPS (diluted)-$1.72-186%

Balance sheet

See full
Cash & equivalents$5.4B-38.2%
Total debt$49.1B+35.8%
Total equity$45.9B-5.1%
Total assets$128.69B+11.8%

Cash flow

See full
Operating cash flow$3.9B+56.7%
Free cash flow$2.9B+150%

Valuation

See full
Market cap$309.84B+56.1%
Enterprise value$353.54B+56.5%
P/E34.7×+23.3×
P/S4.7×+1.6×

Profitability

See full
Gross margin73.9%-2.5pp
Net margin13.6%-13.7pp
FCF margin21.5%-5.2pp

Returns & leverage

See full
Return on equity19%-20.3pp
Debt / equity1.1×+0.3×
Current ratio1.3×-0.1×

Where this comes from

Reported directly by Merck & Co. in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

The official record: Merck & Co.’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Merck & Co.'s capex.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Merck & Co.'s capex?
Merck & Co. (MRK) reported capex of $991M in Q1 2026.
How has Merck & Co.'s capex changed year-over-year?
Merck & Co.'s capex decreased by 25.4% year-over-year, from $1.33B to $991M.
What is the long-term trend for Merck & Co.'s capex?
Over 4 years (2021 to 2025), Merck & Co.'s capex has grown at a -1.9% compound annual growth rate (CAGR), from $4.45B to $4.11B.
What does capex mean?
Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.